European Resuscitation Council Guidelines for Resuscitation 2015 Section 1. Executive summary, Resuscitation, vol.95, pp.951-80, 2015. ,
Characteristics and prognosis of sudden cardiac death in Greater Paris: population-based approach from the Paris Sudden Death Expertise Center, Intensive Care Med, vol.40, pp.846-54, 2014. ,
European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Postresuscitation Care 2015. Section 5 of the European Resuscitation Council Guidelines for Resuscitation, Resuscitation, vol.95, pp.202-224, 2015. ,
Predictors of poor neurological outcome in adult comatose survivors of cardiac arrest: A systematic review and meta-analysis. Part 2: Patients treated with therapeutic hypothermia, Resuscitation, vol.84, pp.1324-1362, 2013. ,
Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, vol.67, pp.203-213, 2006. ,
Prognostication after cardiac arrest: a tale of timing, confounders, and self-fulfillment, Neurology, vol.77, pp.1324-1329, 2011. ,
S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment, Resuscitation, vol.82, pp.26-31, 2011. ,
Neuron Specific Enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management, J Am Coll Cardiol, vol.65, pp.2104-2118, 2015. ,
Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection, Crit Care, vol.21, p.172, 2017. ,
Single versus serial measurements of Neuron-Specific Enolase and prediction of poor neurological outcome in persistently unconscious patients after out-of-hospital cardiac arrest -A TTM-trial substudy, Plos One, vol.12, p.168894, 2017. ,
Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score, Eur Heart J, vol.27, pp.2840-2845, 2006. ,
Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study, Crit Care, vol.13, p.168, 2009. ,
Serial lactate determinations for prediction of outcome after cardiac arrest, Medicine (Baltimore), vol.83, pp.274-283, 2004. ,
Blood ammonia and lactate levels on hospital arrival as a predictive biomarker in patients with out-of-hospital cardiac arrest, Resuscitation, vol.82, pp.404-413, 2011. ,
The CAHP (Cardiac Arrest Hospital Prognosis) score: a tool for risk stratification after out-of-hospital cardiac arrest, Eur Heart J, vol.37, pp.3222-3230, 2016. ,
Prognostic implications of blood lactate concentrations after cardiac arrest: a retrospective study, Ann Intensive Care, vol.7, p.101, 2017. ,
A novel scoring system for predicting the neurological prognosis prior to the initiation of induced hypothermia in cases of post-cardiac arrest syndrome: the CAST score, Resuscitation Emerg Medicine, vol.25, p.49, 2017. ,
S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review, Critical Care, vol.13, p.121, 2009. ,
Increased Serum Levels of the S-100 Protein Are Associated With Hypoxic Brain Damage after CA, vol.29, pp.473-480, 1998. ,
Laterre PF; for the SRLF Trial Group. Changes in cardiac arrest patients' temperature management after the 2013 "TTM" trial: results from an international survey, Ann Intensive Care, vol.6, issue.1, p.4, 2016. ,
Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study, Critical Care, vol.13, p.58, 2009. ,
Serum S100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. Resuscitation, vol.80, pp.870-875, 2009. ,
S-100B protein: An early prognostic marker after cardiac arrest, Cardiol J, vol.17, issue.5, pp.532-538, 2010. ,
Modeling Serum Biomarkers S100 Beta and Neuron-Specific Enolase as Predictors of Outcome After Out-of-Hospital Cardiac Arrest. An Aid to Clinical Decision Making, J Am Coll Cardiol, vol.60, pp.304-315, 2012. ,
Brain biomarkers and management of uncertainty in predicting outcome of cardiopulmonary resuscitation: A nomogram paints a thousand words, Resuscitation, vol.84, pp.1083-1091, 2013. ,
Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia, Resuscitation, vol.80, pp.784-793, 2009. ,
Protein S100 as outcome predictor after out-ofhospital cardiac arrest and targeted temperature management at 33°C and 36°C, Critical Care, vol.21, p.153, 2017. ,
Influence of ?-stat and pH-stat blood gas management strategies on cerebral blood flow and oxygenation in patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest: a crossover study, Crit Care Med, vol.42, issue.8, pp.1849-61, 2014. ,
Targeted temperature management using the "Esophageal Cooling Device" after cardiac arrest (the COOL study): A feasibility and safety study, Resuscitation, vol.121, pp.54-61, 2017. ,
Targeted temperature management at 33°C versus 36°C after cardiac arrest, N Engl J Med, vol.369, pp.2197-206, 2013. ,
European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia); and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Resuscitation, vol.132, pp.328-368, 2015. ,
Predictors of poor neurological outcome in adult comatose survivors of cardiac arrest: A systematic review and meta-analysis. Part 1: Patients not treated with therapeutic hypothermia, Resuscitation, vol.84, pp.1310-1333, 2013. ,
Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with therapeutic hypothermia, Stroke, vol.34, pp.2881-86, 2003. ,
Modeling Serum level of S100B and Bispectral Index to predict outcome after cardiac arrest, J Am Coll Cardiol, vol.62, pp.851-859, 2013. ,
Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest, Resuscitation, vol.85, pp.1025-1034, 2014. ,
NSE and S-100B are not sufficiently predictive of neurologic outcome after therapeutic hypothermia for cardiac arrest, Resuscitation, vol.84, pp.1382-86, 2013. ,
Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome, Resuscitation, vol.85, pp.1654-61, 2014. ,
Neuron-specific enolase and S-100b in prolonged targeted temperature management after cardiac arrest: A randomised study, Resuscitation, vol.122, pp.79-86, 2018. ,
Astroglial Protein S-100 Is an Early and Sensitive Marker of Hypoxic Brain Damage and Outcome After Cardiac Arrest in Humans, Circulation, vol.103, pp.2694-98, 2001. ,
Serum neuron specific enolase -impact of storage and measuring method, BMC Res Notes, 2014. ,
, Les différences entre les courbes ROC étaient significatives entre la PS100B à J0 et tous les autres biomarqueurs à J0 (p<0,0001), ainsi qu'entre la lactatémie à J0 et la NSE àJ0
, Les différences entre les AUC étaient significatives entre la PS100B à J1 et tous les autres biomarqueurs (p<0,001), entre la NSE à J1 et tous les autres biomarqueurs (p<0,001), ainsi qu'entre la lactatémie à J1 ou la créatininémie à J1
, PS100B J2 (AUC 0,809) Lactatémie J2 (AUC 0,547) NSE J2 (AUC 0,778) Créatininémie J2 (AUC 0,598) J0 (p<0,0001), ainsi qu'entre la lactémie à J0 et la NSE à J0. PS100B J0 (AUC 0,831) Lactatémie J0 (AUC 0,709) NSE J0 (AUC 0,585) Créatininémie J0 (AUC 0,658) la NSE à J1 (p<0,0001), et entre la NSE à J1 et la lactatémie à J1. PS100B J1 (AUC 0,825) Lactatémie J1
, Les différences entre les AUC étaient significatives entre la PS100B à J2 et la NSE à J2 versus tous les autres biomarqueurs
, PS100B J2 (AUC 0,818) Lactatémie J2 (AUC 0,551) NSE J2 (AUC 0,776) Créatininémie J2, p.605
, Rôle de la Protéine S-100B pour l'évaluation précoce du pronostic neurologique dans la phase aiguë après arrêt cardiaque